| CAS编号 | 中文名 | 英文名 | 分子式 | 分子量 | 熔点 | 沸点 |
| 1632119-76-6 | | (2e)-3-(2,4-dimethoxyphenyl)-1-(2,5-dimethoxyphenyl)prop-2-en-1-one | | | | |
| 163213-19-2 | 6-肼基烟酸叔丁酯 | tert-butyl 6-hydrazinylnicotinate | C10H15N3O2 | 209.25 | | 317.0±52.0°C |
| 163213-29-4 | | dimethyl 1-(2-bromoethyl)-1h-pyrazole-3,5-dicarboxylate | | | | |
| 163213-38-5 | | methyl 4-oxo-4h,5h,6h,7h,8h-pyrazolo[1,5-a][1,4]diazepine-2-carboxylate | | | | |
| 1632140-86-3 | (S)-4-苄基-2-(吡嗪-2-基)-4, 5-二氢恶唑 | (S)-4-Benzyl-2-(pyrazin-2-yl)-4, 5-dihydrooxazole | C14H13N3O | 239.27 | | |
| 1632140-87-4 | (S)-4-苯基-2-(吡嗪-2-基)-4, 5-二氢恶唑 | (S)-4-Phenyl-2-(pyrazin-2-yl)-4, 5-dihydrooxazole | C13H11N3O | 225.24 | | |
| 1632140-88-5 | (S)-4-异丙基-2-(吡嗪-2-基)-4, 5-二氢恶唑 | (S)-4-Isopropyl-2-(pyrazin-2-yl)-4, 5-dihydrooxazole | C10H13N3O | 191.22 | | |
| 1632145-10-8 | | n-ethyl-n-isopropylpropan-2-aminium 4-oxo-3-(perfluoropyridin-4-yl)-1,5-dioxaspiro[5.5]undec-2-en-2-olate | | | | |
| 1632145-16-4 | | n-ethyl-n-isopropylpropan-2-aminium 4-oxo-3-(2,3,5,6-tetrafluoro-4-nitrophenyl)-1,5-dioxaspiro[5.5]-undec-2-en-2-olate | | | | |
| 1632145-20-0 | | n-ethyl-n-isopropylpropan-2-aminium 4-oxo-3-(2,3,5,6-tetrafluoro-4-(methoxycarbonyl)phenyl)-1,5-dioxaspiro[5.5]undec-2-en-2-olate | | | | |
| 1632145-26-6 | | n-ethyl-n-isopropylpropan-2-aminium 3-(4-acetyl-2,3,5,6-tetrafluorophenyl)-4-oxo-1,5-dioxaspiro[5.5]-undec-2-en-2-olate | | | | |
| 1632145-32-4 | | n-ethyl-n-isopropylpropan-2-aminium 3-(4-cyano-2,3,5,6-tetrafluorophenyl)-4-oxo-1,5-dioxaspiro[5.5]-undec-2-en-2-olate | | | | |
| 1632145-34-6 | | n-ethyl-n-isopropylpropan-2-aminium 3-(3-chloro-2,5,6-trifluoropyridin-4-yl)-4-oxo-1,5-dioxaspiro[5.5]-undec-2-en-2-olate | | | | |
| 1632145-37-9 | | 3-methyl-3-(perfluoropyridin-4-yl)-1,5-dioxaspiro[5.5]undecane-2,4-dione | | | | |
| 1632145-38-0 | | 3-(perfluoropyridin-4-yl)-3-propyl-1,5-dioxaspiro[5.5]undecane-2,4-dione | | | | |
| 1632145-40-4 | | 3-propyl-3-(2,3,5,6-tetrafluoro-4-nitrophenyl)-1,5-dioxaspiro[5.5]undecane-2,4-dione | | | | |
| 1632145-41-5 | | 4-(2,4-dioxo-3-propyl-1,5-dioxaspiro[5.5]-undecan-3-yl)-2,3,5,6-tetrafluorobenzonitrile | | | | |
| 1632145-44-8 | | 3-propyl-3-(2,3,5,6-tetrafluoro-4-(trifluoromethyl)phenyl)-1,5-dioxaspiro[5.5]undecane-2,4-dione | | | | |
| 1632165-25-3 | | (2e)-1-(4-bromophenyl)-3-(3-methylphenyl)prop-2-en-1-one | | | | |
| 1632165-26-4 | | (2e)-3-(2-fluorophenyl)-1-(4-methylphenyl)prop-2-en-1-one | | | | |
| 163217-09-2 | Inecalcitol | | C26H40O3 | 400.59 | | |
| 163217-43-4 | | fmoc-p-azido-phe-oh | C24H20N4O4 | 428.44 | | |
| 163217-74-1 | O-Hydroxy atorvastatin lactone | 2-Hydroxy atorvastatin lactone | C33H33FN2O5 | 556.62 | | |
| 16322-13-7 | | naphthalene,2,2',2''-(1,2,5-benzenetriyl)tris- | C36H24 | 456.58 | 234-235℃ | 653.4±50.0 °C(Predicted) |
| 16322-14-8 | | 1(2h)-quinolinecarboxylic acid, ethyl ester | | | | |
| 16322-19-3 | | 4-nitro-benzofuraza | | | | |
| 16322-23-9 | | 4-nitro-7-phenylthio-benzofuraza | | | | |
| 163220-69-7 | 2,2,2-三氯-1-(1h-吡咯并[2,3-b]吡啶-3-基)乙酮 | 2,2,2-trichloro-1-(1h-pyrrolo[2,3-b]pyridin-3-yl)ethanone | C9H5Cl3N2O | 263.5100 | | |
| 163222-32-0 | (3R,4S)-1-(4-氟苯基)-3-[(3S)-3-(4-氟苯基)-3-羟基丙基]-4-[4-(苯甲氧基)苯基]-2-氮杂环丁酮 | (3R,4S)-4-(4-(benzyloxy)phenyl)-1-(4-fluorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)azetidin-2-one | C31H27F2NO3 | 499.55 | | 706.462°C at 760 mmHg |
| 163222-33-1 | 依替米贝 | | C24H21F2NO3 | 409.43 | 164-166°C | |
| 1632228-23-9 | 7-oxaspiro[3.5]nonan-2-amine;hydrochloride | | C8H15NO.HCl | 177.6711 | | |
| 1632236-44-2 | | klh45 | | | | |
| 1632236-60-2 | 唑来膦酸ep杂质b | zoledronic acid ep impurity b | | | | |
| 1632243-18-5 | N4-Acetyl-3'-O-(4,4'-dimethoxytrityl)-2'-deoxycytidine-5'-cyanoethyl | | C41H50N5O8P | 771.84 | | |
| 1632250-49-7 | (R)-4-(3H-[1,2,3]三唑并[4,5-b]吡啶-3-基)-N-(3-氯吡啶-2-基)-N-(哌啶-3-基)苯甲酰胺 | (R)-4-(3H-[1,2,3]Triazolo[4,5-b]pyridin-3-yl)-N-(3-chloropyridin-2-yl)-N-(piperidin-3-yl)benzamide | C22H20ClN7O | 433.89 | | 655.5±65.0 °C(Predicted) |
| 1632250-50-0 | pf-06446846 盐酸盐 | pf-06446846 hydrochloride | C22H21Cl2N7O | 470.35 | | |
| 1632250-93-1 | (1R)-1-[5-(1-甲基-4-{4-[(3-甲基吡啶-2-基)[(3R)-哌啶-3-基]氨基甲酰基]苯基}-1h-吡唑-5-h)-1h-1,2,3,4-四唑-2-基]乙基2-甲基丙酸酯 | (1R)-1-[5-(1-methyl-4-{4-[(3-methylpyridin-2-yl)[(3R)-piperidin-3-yl]carbamoyl]phenyl}-1h-pyrazol-5-yl)-2h-1,2,3,4-tetrazol-2-yl]ethyl 2-methylpropanoate | | | | |
| 1632250-94-2 | (1S)-1-[5-(1-甲基-4-{4-[(3-甲基吡啶-2-基)[(3R)-哌啶-3-基]氨基甲酰基]苯基}-1h-吡唑-5-h)-1h-1,2,3,4-四唑-2-基]乙基2-甲基丙酸酯 | (1S)-1-[5-(1-methyl-4-{4-[(3-methylpyridin-2-yl)[(3R)-piperidin-3-yl]carbamoyl]phenyl}-1h-pyrazol-5-yl)-2h-1,2,3,4-tetrazol-2-yl]ethyl 2-methylpropanoate | | | | |
| 163226-45-7 | (3as,4S,6ar)-2,2-二甲基-6-((三苯甲基氧基)甲基)-4,6a二氢-3ah-环戊二烯并[d] [1,3]二氧杂环戊烯-4-醇 | (3as,4S,6ar)-2,2-dimethyl-6-((trityloxy)methyl)-4,6a-dihydro-3ah-cyclopenta[d][1,3]dioxol-4-ol | C28H28O4 | 428.52 | 137-139 °C | 553.9±50.0 °C(Predicted) |
| 163228-38-4 | | 6-O-(tert-Butyldimethylsilyl)-D-galactal cyclic carbonate | | | 45-49℃ | |
| 1632285-87-0 | (2-甲氧基嘧啶-4-基)甲胺盐酸盐 | (2-methoxypyrimidin-4-yl)methanamine hydrochloride | C6H10ClN3O | 175.62 | | |
| 1632285-92-7 | 1-(2-氨基-4,6-二氟苯基)乙酮 | 1-(2-amino-4,6-difluorophenyl)ethanone | C8H7F2NO | 171.14 | | |
| 1632285-93-8 | | 2-(bromomethyl)-3,5-dimethylpyridine hydrobromide | C8H11Br2N | 280.99 | | |
| 1632285-95-0 | 5-溴-2-嘧啶甲胺氢溴酸盐 | (5-bromopyrimidin-2-yl)methanamine hydrobromide | C5H7Br2N3 | 268.94 | | |
| 1632285-97-2 | 6-氯吲哚嗪 | 6-Chloroindolizine | C8H6ClN | 151.59 | | |
| 1632285-98-3 | ((2-甲氧基嘧啶-4-基)甲基)氨基甲酸叔丁酯 | tert-butyl ((2-methoxypyrimidin-4-yl)methyl)carbamate | C11H17N3O3 | 239.27 | | |
| 1632285-99-4 | | 2-chloro-5-methoxy-3-methyl-tetrahydro-pyrimidin-4-one | | | | |
| 1632286-02-2 | | trifluoro-methanesulfonic acid 8-methoxy-3-phenyl-[1,7]naphthyridin-2-yl ester | | | | |
| 1632286-03-3 | | (4-chloro-2-formyl-5-methoxy-phenyl)-carbamic acid tert-butyl ester | | | | |
| 1632286-05-5 | | n-(3-chloro-4-fluorophenyl)-n-(7-fluoro-6-nitroquinazolin-4-yl)acetamide | | | | |
m.cnreagent.com